semaglutide approved for cardiovascular Novo Nordisk's Wegovy disease treatment in China MHRA approves new use of

222 (2.1%) patients in the semaglutide group experienced a cardiovascular event, compared with 251 (3.5%) in the placebo group

This creates deficiencies that can manifest as fatigue, brain fog, and slowed metabolism

Consuming protein within several hours before and after resistance exercise maximizes the anabolic stimulus

These guides show how water types, volume choices, and steady movements affect your results

PMCID: PMC10836305 Gandolfi JV, Di Bernardo APA, Chanes DAV, Martin DF, Joles VB, Amendola CP, Sanches LC, Ciorlia GL, Lobo SM (2020) The Effects of Melatonin Supplementation on Sleep Quality and Assessment of the Serum Melatonin in ICU Patients: A Randomized Controlled Trial